CL2018002644A1 - Oclusión fístula pancreática. - Google Patents

Oclusión fístula pancreática.

Info

Publication number
CL2018002644A1
CL2018002644A1 CL2018002644A CL2018002644A CL2018002644A1 CL 2018002644 A1 CL2018002644 A1 CL 2018002644A1 CL 2018002644 A CL2018002644 A CL 2018002644A CL 2018002644 A CL2018002644 A CL 2018002644A CL 2018002644 A1 CL2018002644 A1 CL 2018002644A1
Authority
CL
Chile
Prior art keywords
pancreatic fistula
self
assembling peptide
occlusion
pancreatic
Prior art date
Application number
CL2018002644A
Other languages
English (en)
Spanish (es)
Inventor
Satoru Kobayashi
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of CL2018002644A1 publication Critical patent/CL2018002644A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
CL2018002644A 2016-03-18 2018-09-14 Oclusión fístula pancreática. CL2018002644A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662310124P 2016-03-18 2016-03-18

Publications (1)

Publication Number Publication Date
CL2018002644A1 true CL2018002644A1 (es) 2019-07-05

Family

ID=58672629

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018002644A CL2018002644A1 (es) 2016-03-18 2018-09-14 Oclusión fístula pancreática.

Country Status (9)

Country Link
US (1) US20200078489A1 (enExample)
EP (1) EP3429646A1 (enExample)
JP (1) JP2019508175A (enExample)
CN (1) CN109152861A (enExample)
AU (1) AU2017235871A1 (enExample)
BR (1) BR112018068838A2 (enExample)
CL (1) CL2018002644A1 (enExample)
MX (1) MX2018011120A (enExample)
WO (1) WO2017158432A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12377196B2 (en) 2016-03-18 2025-08-05 3-D Matrix, Ltd. Preventing biological tissue adhesion

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6912953B2 (ja) * 2016-06-27 2021-08-04 三洋化成工業株式会社 体液漏出防止剤
CN113194976A (zh) * 2018-10-05 2021-07-30 学校法人久留米大学 用于肠道中的溃疡或瘘管的治疗或预防的医药组合物
US20230078523A1 (en) * 2020-02-28 2023-03-16 Menicon Co., Ltd. Digestive fluid leak preventative material and organ protective material against digestion by digestive fluid
CN115397454A (zh) 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌
CN111939323B (zh) * 2020-08-08 2022-06-10 武汉速普生物科技有限公司 含有透明质酸连接肽和连接蛋白末端肽的功能性多肽水凝胶及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100102750A (ko) * 2005-04-25 2010-09-24 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법
WO2009049022A1 (en) * 2007-10-10 2009-04-16 Ore Pharmaceuticals Inc. Method for treatment of pancreatitis
CN105435211A (zh) * 2008-10-06 2016-03-30 三维肽胶株式会社 组织闭塞剂
WO2014141160A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd Treatment for bile leakage
CN105342984A (zh) * 2014-08-21 2016-02-24 中国人民解放军总医院 一种用于治疗急性胰腺炎的可注射温敏凝胶制剂

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12377196B2 (en) 2016-03-18 2025-08-05 3-D Matrix, Ltd. Preventing biological tissue adhesion

Also Published As

Publication number Publication date
EP3429646A1 (en) 2019-01-23
JP2019508175A (ja) 2019-03-28
WO2017158432A1 (en) 2017-09-21
BR112018068838A2 (pt) 2019-01-22
US20200078489A1 (en) 2020-03-12
CN109152861A (zh) 2019-01-04
AU2017235871A1 (en) 2018-09-27
MX2018011120A (es) 2019-03-28

Similar Documents

Publication Publication Date Title
MX2020004883A (es) Composiciones de exosomas modificados y metodos de cargar cargas de exosomas luminales.
MX2018011120A (es) Oclusion de fistula pancreatica.
CO2019005464A1 (es) Dispositivo para aneurisma y sistema de suministro
CO2017004489A2 (es) Polipéptidos fgf-21 modificados
CO2020001627A2 (es) Composiciones de aminoácidos para el tratamiento de lesión neuronal
CO2018004564A2 (es) Genes de ataxia de friedreich modificados y vectores para terapia génica
AR088044A1 (es) Proteinas de fusion para tratar trastornos metabolicos
MX2018011491A (es) Disposiciones de secuencia y secuencias para presentacion de neoepitopos.
CL2017001883A1 (es) Compuestos antisenescentes y usos de los mismos
MX387560B (es) Procedimiento para mejorar la solubilidad de proteínas y péptidos usando un enlace del fragmento fc de inmunoglobulina.
MX2020010262A (es) Manufactura de neurotoxinas de clostridium botulinum recombinantes.
MX387816B (es) Dispositivos para estabilización de articulación y hueso de tensión activa.
PL3226854T3 (pl) Kompozycja na bazie aminokwasów do odbudowy fibroelastyny w tkance łącznej skóry
MX2016014050A (es) Combinacion de un acido hialuronico y un polisacarido sulfatado.
MX2019001633A (es) Proteina derivada de la seda para el tratamiento de la inflamacion.
AR105089A1 (es) ANTICUERPOS ANTI-TAU(pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
BR112018001435A2 (pt) métodos para entrega linfática de agentes ativos
CL2020000733A1 (es) Proteína de fusión que comprende una porción de fgf-18.
CL2018002646A1 (es) Prevención de la adherencia del tejido biológico.
CL2017003144A1 (es) Péptidos lipidados resistentes a proteasas
MX2016014122A (es) Metodo para la fabricacion de un tapon para cuello de recipiente.
BR112018072968A2 (pt) peptídeos monolipidados resistentes às proteases
CL2018002643A1 (es) Oclusión de fuga de líquido cefalorraquideo.
AR098615A1 (es) Péptido para el tratamiento de hipoglicemia severa